🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Real-world data on dupilumab in a cohort of 70 #EoE patients from Michigan. Among the 52 who had histological evaluation, remission (<15 eos/HPF) was achieved in 92.3% in first line, 85% after failure of previous treatment. Non-GI doctors used it as 1st-line therapy AJG - The American Journal of Gastroenterology

Updated prevalence of #EosinophilicEsophagitis in the USA from two large administrative databases: Overall, 1 in 617 people <65 years of age and 1 in 1,562 of those ≥65 years of age currently have #EoE. Associated annual costs were estimated to be $1.3 billion in 2024 CGH

Positive results in terms of histological, clinical and endoscopic improvements with new EsoCap device coated with mometasone. A technical innovation for topical drug administration in the esophagus, tested for the first time in patients with #EosinophilicEsophagotis aedeseo - EoE

From EUREOS we wish everyone a Merry Christmas and Happy Holidays! Thank you to all the members and associates for their support to our activities in 2024, aimed to share knowledge about eosinophilic GI diseases to better help our patients through research and education

New ACG Guidelines recommends proton pump inhibitors, topical steroids, empiric diet elimination, a biologic, and esophageal dilation as treatments for #EosinophilicEsophagitis. Read full document at journals.lww.com/ajg/fulltext/2… AJG - The American Journal of Gastroenterology

The first study to comprehensively map the histology and morphometry of upper GI tract biopsies just defined a “gold standard” of normality. Results suggest that, when healthy subjects are not accesible, GERD subjects may serve as control group IJMS MDPI mdpi.com/1422-0067/26/3…

Data on long term maintenance on Jorveza just released: After 96 weeks, 81.9% #EoE patients were in clinical remission; 80.1% of them also had <5 eos/hpf). Symptomatic candidiasis was confirme in 5 out of 186 patients. Full text at: cghjournal.org/article/S1542-… DR FALK CGH

Real-world Effectiveness of Dupilumab in #EoE provided in a meta-analysis of 5 cohort studies, with 209 patients: Overall, 89.2% of patients had any symptom improvement. As for histology, 90.6% of patients had ≤15 and 71.3% had ≤6 eos/hpf, after dupilumab therapy JCG Online

Cumulative dosis of corticosteroids in incident patients with #EoE who usually have coexisting type 2 inflammatory conditions (asthma, rhinitis, atopic dermatitis) surpasses those of matched atopic non-EoE controls. Study results based on real-world claims data CGH Sanofi

Incidence of non-esophageal eosinophilic gastrointestinal disorders in a nationwide, population-based cohort found it affects 1 in 1250 females and 1 in 1667 males in Sweden, with increasing trends over time. Eosinophilic colitis was the most common type Taylor & Francis Research Insights EOS Network Eosinophilic Diseases Charity

An analysis of 340 patients of the Swiss #EosinophilicEsophagitis Cohort (26% of them being prior non-responders to off-label topical corticosteroids) found budesonide orodispersible tablets was similarly effective in achieving response regardless of previous therapy AJG - The American Journal of Gastroenterology

📅 El 22 de mayo de 2025 se celebrará por primera vez el #DíaMundialEoE 🌍 Una fecha clave para dar visibilidad a la Esofagitis Eosinofílica (EoE) 💙 👉 📝 Webinar 22 mayo «Día Mundial de la EoE!»: acortar.link/F0qYhz #EoEday aedeseo - EoE EUREOS

The First-Ever World Eosinophilic Esophagitis Day – May 22, 2025! proudly supported by EUREOS. We join claims to share knowledge, support research, provide compassion and advocate for change around EoE aedeseo - EoE Global Allergy & Airways Patient Platform EOS Network Eosinophilic Diseases Charity APFED.org ausEE Inc. my_UEG CURED Foundation

📢#EoEday #DíaMundialEoE | Hoy, 22 de mayo de 2025, se conmemora por primera vez el Día Mundial de la Esofagitis Eosinofílica (EoE). 👉Impulsado por aedeseo - EoE, la Global Allergy & Airways Patient Platform y EUREOS, este día nace con la voluntad de unir a pacientes y profesionales sanitarios en torno a una

📅 Hoy 22 de mayo de 2025 se celebra el #DíaMundialEoE 🌍 Una fecha clave para dar visibilidad a la Esofagitis Eosinofílica (EoE) 💙 👉 Aún estas a tiempo de registrarte! 📝 Webinar 22 mayo «Día Mundial de la EoE! 👉 acortar.link/F0qYhz #EoEday aedeseo - EoE EUREOS

EUREOS contributes to disseminating best scientific and clinical knowledge about #EosinophilicEsophagitis with EUREOS Library. Register on the largest specialized educational platform and obtain credits CME for free! Aegastro SEED SEMERGEN | Médicos de AP #SEMERGEN25 SEICAP #WorldEOEDay

Hoy 22 de mayo de 2025 se celebra, por primera vez, el Día Mundial de la Esofagitis Eosinofílica (#EoE), que ha sido posible por la alianza de aedeseo - EoE con la Global Allergy & Airways Patient Platform (Global Allergy & Airways Patient Platform) y EUREOS #DíaMundialEoE #EoEday n9.cl/w5sx5m

🟣 Multidisciplinary care is essential for #eosinophilicdiseases. Like and share: ow.ly/YqwF50VXAG1 Huge thanks to our incredible partners advancing this work 👇 EUREOS International Eosinophil Society Guts UK Charity EAACI Beacon for Rare Diseases @my_UEG @auseeorg aedeseo - EoE #EAM2025

Protective effect of H pylori infection over #EoE was supported by retrospective studíes with high risk of bias. while not observed in the few ones with a prospective and propper design. More well-designed research is required to answer this question

EUREOS supports claims of organizations of patients with #EoE in the Manifesto for World EoE 2025 Day read today in many places around the globe. Access the full text of the Manifesto at eoeday.org/manifesto/ aedeseo - EoE EOS Network Eosinophilic Diseases Charity ausEE Inc. Eseo italia APFED.org #WorldEoEDay